CJC-1295 with DAC

CJC-1295 with DAC Research Peptide CJC-1295 with DAC (Drug Affinity Complex) is a modified synthetic analog of growth hormone-releasing hormone (GHRH) consisting of 30 amino acids. The addition of the Drug Affinity Complex significantly extends the peptide's biological half-life by binding to albumin in the bloodstream, allowing for sustained research applications. This compound has been extensively studied in the context of growth hormone (GH) and insulin-like growth factor 1 (IGF-1) secretion pathways. Research has demonstrated that CJC-1295 with DAC can maintain elevated GH levels for extended periods compared to non-DAC variants, making it particularly valuable for longitudinal research designs. Key Research Areas: - Growth hormone secretion pathway studies - IGF-1 modulation research - Pituitary function investigations - Sustained-release peptide pharmacokinetics - Metabolic pathway research Composition per vial: CJC-1295 with DAC — 5mg Storage: Store at -20°C for long-term stability. Reconstituted solutions should be stored at 2-8°C. Handling: Follow appropriate laboratory handling procedures. Disclaimer: This product is intended for research purposes only. Not for human consumption.